Webinar Webinar: il meccanismo di adeguamento del carbonio alle frontiere (CBAM) spiegato alle aziende svizzere Jun 18, 2024 10:00–11:00
News May 06, 2024 EY reports growth of 53 percent for investments in Switzerland Foreign investments in Europe fell by 4 percent in 2023. However, investments in Switzerland were up by 53 percent. These findings were reported ...
News Apr 17, 2024 Symbio invests CHF 12 million in new research facility in Corminboeuf Symbio commits CHF 12 million to establish a high-tech hydrogen research center in Corminboeuf, aiming for a 2026 launch.
Actualités Apr 17, 2024 Symbio va investir CHF 12 millions dans un nouveau centre de recherche à Corminboeuf Symbio va consacrer CHF 12 millions pour construire un centre de recherche de pointe sur l’hydrogène à Corminboeuf, avec un lancement prévu en 20...
Webinaire Webinaire: Le mécanisme d’ajustement carbone aux frontières (MACF) expliqué aux entreprises suisses Jun 18, 2024 10:00–11:00
Aktuell Nov 15, 2023 Nouscom erhält 67,5 Millionen Euro Finanzierung Nouscom hat bei einer Serie C-Finanzierung 67,5 Millionen Euro eingenommen. Das Unternehmen aus Basel will damit die klinische Entwicklung seines...
News Dec 06, 2023 Advance Capital expands its footprint in Switzerland with the opening of a new subsidiary in Geneva Advance Capital, the French financial expert, opens a subsidiary in Geneva, strengthening its presence and offering direct access to the Swiss ma...
News Nov 15, 2023 Nouscom secures 67.5 million euros in financing Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based company intends to use the funds to advance the clinical dev...
Actualités Dec 06, 2023 Advance Capital étend son empreinte en Suisse avec l’implantation d’une nouvelle filiale à Genève Advance Capital, expert français en finance, ouvre une filiale à Genève, renforçant sa présence et offrant un accès direct au marché suisse.
ニュース Jun 02, 2023 欧州のバイオテクノロジー企業の20%がスイスに本社を置いていることが判明 Press release IQVIAが実施し、このほど発表された「2023スイスバイオテックレポート」によると、欧州のバイオテクノロジー企業の20%がスイスに本社を置いていることが明らかになりました。さらに、スイス連邦政府、州、地域による投資促進に関する昨年の統計でも、この傾向が続いていることが確認されています。
SWISS Pavilion SWISS Pavilion @ The Saudi Food Show 2024 May 21, 2024–May 23, 2024 Riyadh Saudi Arabia
News Aug 07, 2023 AQUA4D expands to Chile to open a new chapter in sustainable water innovation AQUA4D, a leading Valais-based water innovation company, continues its international expansion with the launch of a subsidiary in Santiago, Chile...
News Sep 29, 2023 CKW planning geothermal power plant in the canton of Lucerne The CKW Group intends to use deep geothermal energy from the Inwil/Perlen region in the canton of Lucerne to generate heat and electricity. For t...
Aktuell Jun 02, 2023 Neuste Forschung zeigt, dass 20% der europäischen Biotechs ihren Hauptsitz in der Schweiz haben Press release Neue Untersuchungen von IQVIA, die kürzlich im Swiss Biotech Report 2023 veröffentlicht wurden, zeigen, dass mittlerweile 20% der europäischen Bi...
News Aug 24, 2023 Nanomedicine pioneer Nanobacterie achieves remarkable patent ranking Drawing from the achievements of its parent company, Nanobacterie, Valais-based AlphaOnco Swiss stands at the forefront of innovative nanomedicin...
最新 Jun 02, 2023 最新研究显示,目前有20%的欧洲生物科技公司将总部设在瑞士 Press release 由 IQVIA 进行的新研究和最近发布的《2023瑞士生物科技报告》显示,目前有20%的欧洲生物科技公司将总部设在瑞士。此外,瑞士联邦政府、各州和地区去年的投资促进统计数据证实,这一趋势仍在继续。